ATRX

ATRX Full Name

alpha thalassemia/mental retardation syndrome X-linked

ATRX Introduction

ATRX (alpha thalassemia/mental retardation syndrome X-linked), also known as ATRX chromatin remodeler, is an ATP-dependent chromatin remodeling protein belonging to the SWI/SNF family and functions as a critical regulator of genome organization, transcriptional control, and epigenetic stability. For researchers investigating chromatin dysregulation, developmental disorders, or cancer-associated epigenetic mechanisms, ATRX represents an important target because it acts as a "guardian of chromatin" by maintaining proper nucleosome structure and genomic integrity. ATRX forms a functional complex with the histone chaperone DAXX to facilitate the deposition of the histone variant H3.3, particularly at telomeric regions, pericentromeric heterochromatin, ribosomal DNA repeats, and other repetitive genomic elements. Through interactions with chromatin regulators such as HP1α, MECP2, and polycomb-associated proteins, ATRX helps preserve heterochromatin architecture, regulate gene accessibility, and coordinate DNA replication and repair processes.

The primary biological function of ATRX is to maintain epigenetic homeostasis by controlling chromatin remodeling, transcriptional regulation, and responses to replication stress. ATRX suppresses the accumulation of abnormal DNA structures, including R-loops and G-quadruplex (G4) DNA structures, which can interfere with DNA replication and promote genome instability. Loss of ATRX disrupts H3.3 deposition, alters chromatin accessibility, increases DNA damage sensitivity, and promotes alternative lengthening of telomeres (ALT), a telomerase-independent mechanism frequently observed in specific cancer types. Recent studies have demonstrated that ATRX activity extends beyond classical heterochromatin regulation, as it also influences euchromatic regions and cell-specific transcriptional programs. By regulating chromatin dynamics in a context-dependent manner, ATRX contributes to normal cellular differentiation, genome maintenance, and long-term control of gene expression.

ATRX dysfunction is strongly associated with human disease, most notably ATR-X syndrome, an X-linked intellectual disability disorder characterized by developmental delay, distinctive facial features, microcephaly, skeletal abnormalities, and alpha-thalassemia caused by impaired regulation of the α-globin gene cluster. Pathogenic ATRX mutations are also frequently identified in cancers, particularly high-grade gliomas, pancreatic neuroendocrine tumors, and neuroblastomas, where ATRX loss contributes to tumor evolution through chromosomal instability and activation of the ALT pathway. Because ATRX deficiency affects fundamental mechanisms of chromatin regulation and DNA repair, it has become an important biomarker and therapeutic research target for understanding epigenetic diseases and developing precision strategies against ATRX-mutant tumors. Ongoing studies of ATRX-mediated chromatin remodeling, replication stress response, and genome stability continue to provide valuable insights into developmental disorders and cancer vulnerabilities.

Alternate Names for ATRX

ATRX; alpha thalassemia/mental retardation syndrome X-linked; alpha thalassemia/mental retardation syndrome X linked (RAD54 (S. cerevisiae) homolog) , JMS, Juberg Marsidi syndrome , RAD54; transcriptional regulator ATRX; RAD54 homolog (S. cerevisiae); XH

• 1.Aguilera P, López-Contreras AJ. ATRX, a guardian of chromatin. Trends Genet. 2023, 39(6):505-519.
  2.Pang Y, et al.; The Chromatin Remodeler ATRX: Role and Mechanism in Biology and Cancer. Cancers (Basel). 2023, 15(8):2228.